Overview

A Trial to Evaluate the Efficacy and Safety of Two Concentrations of VBP-926 Solution for the Treatment of Chemotherapy-associated Paronychia in Cancer Patients

Status:
Completed

Trial end date:
2018-09-18

Target enrollment:

Participant gender:

Summary

Paronychia is inflammation of the skin surrounding the nail that leads to secondary infection. Iatrogenic paronychia has been clearly associated with cancer chemotherapies. This phase-2 trial is a dose finding study and will evaluate topical VBP-926 solution against a vehicle control.

Phase:

Phase 2

Details

Lead Sponsor:

Veloce BioPharma LLC

Treatments:

Pharmaceutical Solutions